Retrospective assessment of thymoxamine (Opilon) in treatment of Ménières disease.
A retrospective study of 305 patients treated with thymoxamine (Opilon) for Ménières disease is described. Thymoxamine controlled symptoms in 78.7% of patients and the time to maximum improvement ranged from six weeks to three months. Seven patients suffered side-effects.
D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008575:Meniere Disease / Q000188:drug therapy*; D013948:Moxisylyte / Q000627:therapeutic use*; D012189:Retrospective Studies
D013948:Moxisylyte